US2019167844A1PendingUtilityA1
Biodegradable single-phase cohesive hydrogels
Est. expiryDec 7, 2027(~1.4 yrs left)· nominal 20-yr term from priority
A61P 41/00A61P 27/02A61P 13/02A61P 17/00A61P 19/02A61P 17/16A61K 2800/91A61K 8/733A61K 8/731A61L 2400/06A61L 27/52A61K 8/735A61K 31/738A61L 27/58A61K 2800/594A61K 8/736A61L 27/26A61K 8/042A61Q 19/08
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A biodegradable single-phase cohesive hydrogel includes a homogenous mixture of 2 to 5 identical or different polymers interpenetrating each other in a single phase, wherein the polymers are independently crosslinked prior to interpenetration by mixing, and the crosslinked polymers are insoluble in water and miscible with each other.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A biodegradable single-phase cohesive hydrogel, comprising:
a homogenous mixture of 2 to 5 identical or different polymers interpenetrating each other in a single phase, wherein: the polymers are independently crosslinked prior to interpenetration by mixing; and the crosslinked polymers are insoluble in water and miscible with each other.
26 . The hydrogel according to claim 25 , wherein the polymers have different degrees of crosslinking.
27 . The hydrogel according to claim 25 , wherein the polymers have identical degrees of crosslinking.
28 . The hydrogel according to claim 25 , wherein each polymer is a polysaccharide.
29 . The hydrogel according to claim 28 , wherein each polysaccharide is selected from the group consisting of hyaluronic acid, keratan, heparin, cellulose, cellulose derivatives, alginic acid, xanthan, carrageenan, chitosan, chondroitin, and biologically acceptable salts thereof.
30 . The hydrogel according to claim 28 , wherein each polysaccharide is hyaluronic acid or a biologically acceptable salt thereof.
31 . The hydrogel according to claim 28 , wherein at least one polysaccharide is selected from the group consisting of cellulose derivatives and biologically acceptable salts thereof.
32 . The hydrogel according to claim 28 , wherein at least one polysaccharide is selected from the group consisting of chondroitin and biologically acceptable salts thereof.
33 . The hydrogel according to claim 28 , wherein at least one polysaccharide is selected from the group consisting of chitosan and biologically acceptable salts thereof.
34 . The hydrogel according to claim 25 , wherein the homogenous mixture is of 2 polymers.
35 . The hydrogel according to claim 25 , further comprising one or more active principles selected from the group consisting of antioxidants, antiseptics, anti-inflammatories, local anesthetics, and mixtures thereof.
36 . The hydrogel according to claim 25 , further comprising at least one antioxidant selected from the group consisting of mannitol and sorbitol.
37 . The hydrogel according to claim 25 , further comprising a local anesthetic.
38 . A kit comprising the hydrogel according to claim 25 packaged in a sterile syringe.
39 . A process of preparing a biodegradable single-phase cohesive hydrogel, comprising:
independently crosslinking 2 to 5 polymers to obtain 2 to 5 identical or different crosslinked polymers; and interpenetrating the crosslinked polymers by mixing to obtain a homogenous mixture of the crosslinked polymers in a single phase, wherein the crosslinked polymers are insoluble in water and miscible with each other.
40 . The process according to claim 39 , wherein crosslinking is performed using a bi- or polyfunctional crosslinking agent selected from the group consisting of bi- or polyfunctional epoxy compounds and divinyl sulfone.
41 . The process according to claim 39 , wherein each polymer has a degree of crosslinking within a range from 0.02 to 0.4.
42 . A method of cosmetic injection comprising injecting the hydrogel according to claim 25 to fill a wrinkle, skin defect, or volume defect of a patient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.